Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2019	Sep. 30, 2018	Sep. 29, 2019	Sep. 30, 2018
Sales by segment of business
Sales to customers	$ 20,729	$ 20,348	$ 61,312	$ 61,187
Percent Change (as a percent)	1.90%		0.20%
U.S.
Sales by segment of business
Sales to customers	$ 10,791	10,664	$ 31,323	31,255
Percent Change (as a percent)	1.20%		0.20%
International
Sales by segment of business
Sales to customers	$ 9,938	9,684	$ 29,989	29,932
Percent Change (as a percent)	2.60%		0.20%
CONSUMER
Sales by segment of business
Sales to customers	$ 3,469	3,415	$ 10,331	10,317
Percent Change (as a percent)	1.60%		0.10%
CONSUMER | U.S.
Sales by segment of business
Sales to customers	$ 1,394	1,370	$ 4,369	4,282
Percent Change (as a percent)	1.70%		2.00%
CONSUMER | International
Sales by segment of business
Sales to customers	$ 2,075	2,045	$ 5,962	6,035
Percent Change (as a percent)	1.40%		(1.20%)
CONSUMER | Baby Care
Sales by segment of business
Sales to customers	$ 417	472	$ 1,254	1,385
Percent Change (as a percent)	(11.60%)		(9.50%)
CONSUMER | Baby Care | U.S.
Sales by segment of business
Sales to customers	$ 91	120	$ 277	306
Percent Change (as a percent)	(24.10%)		(9.50%)
CONSUMER | Baby Care | International
Sales by segment of business
Sales to customers	$ 326	352	$ 977	1,079
Percent Change (as a percent)	(7.30%)		(9.50%)
CONSUMER | Beauty
Sales by segment of business
Sales to customers	$ 1,151	1,078	$ 3,443	3,271
Percent Change (as a percent)	6.80%		5.30%
CONSUMER | Beauty | U.S.
Sales by segment of business
Sales to customers	$ 559	543	$ 1,810	1,791
Percent Change (as a percent)	2.90%		1.10%
CONSUMER | Beauty | International
Sales by segment of business
Sales to customers	$ 592	535	$ 1,633	1,480
Percent Change (as a percent)	10.80%		10.40%
CONSUMER | Oral Care
Sales by segment of business
Sales to customers	$ 379	384	$ 1,135	1,156
Percent Change (as a percent)	(1.40%)		(1.80%)
CONSUMER | Oral Care | U.S.
Sales by segment of business
Sales to customers	$ 156	158	$ 462	472
Percent Change (as a percent)	(1.10%)		(2.10%)
CONSUMER | Oral Care | International
Sales by segment of business
Sales to customers	$ 223	226	$ 673	684
Percent Change (as a percent)	(1.60%)		(1.70%)
CONSUMER | OTC
Sales by segment of business
Sales to customers	$ 1,098	1,048	$ 3,249	3,186
Percent Change (as a percent)	4.80%		2.00%
CONSUMER | OTC | U.S.
Sales by segment of business
Sales to customers	$ 477	440	$ 1,468	1,359
Percent Change (as a percent)	8.40%		8.00%
CONSUMER | OTC | International
Sales by segment of business
Sales to customers	$ 621	608	$ 1,781	1,827
Percent Change (as a percent)	2.20%		(2.50%)
CONSUMER | Women's Health
Sales by segment of business
Sales to customers	$ 255	269	$ 733	792
Percent Change (as a percent)	(5.30%)		(7.40%)
CONSUMER | Women's Health | U.S.
Sales by segment of business
Sales to customers	$ 3	3	$ 9	10
Percent Change (as a percent)	(4.00%)		(3.80%)
CONSUMER | Women's Health | International
Sales by segment of business
Sales to customers	$ 252	266	$ 724	782
Percent Change (as a percent)	(5.40%)		(7.50%)
CONSUMER | Wound Care/Other
Sales by segment of business
Sales to customers	$ 168	164	$ 516	527
Percent Change (as a percent)	2.40%		(2.00%)
CONSUMER | Wound Care/Other | U.S.
Sales by segment of business
Sales to customers	$ 109	106	$ 343	344
Percent Change (as a percent)	1.90%		(0.40%)
CONSUMER | Wound Care/Other | International
Sales by segment of business
Sales to customers	$ 59	58	$ 173	183
Percent Change (as a percent)	3.30%		(5.00%)
PHARMACEUTICAL
Sales by segment of business
Sales to customers	$ 10,877	10,346	$ 31,650	30,544
Percent Change (as a percent)	5.10%		3.60%
PHARMACEUTICAL | U.S.
Sales by segment of business
Sales to customers	$ 6,340	6,097	$ 17,705	17,350
Percent Change (as a percent)	4.00%		2.00%
PHARMACEUTICAL | International
Sales by segment of business
Sales to customers	$ 4,537	4,249	$ 13,945	13,194
Percent Change (as a percent)	6.80%		5.70%
PHARMACEUTICAL | Immunology
Sales by segment of business
Sales to customers	$ 3,711	3,398	$ 10,428	9,778
Percent Change (as a percent)	9.30%		6.70%
PHARMACEUTICAL | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 2,582	2,400	$ 7,124	6,717
Percent Change (as a percent)	7.60%		6.10%
PHARMACEUTICAL | Immunology | International
Sales by segment of business
Sales to customers	$ 1,129	998	$ 3,304	3,061
Percent Change (as a percent)	13.20%		8.00%
PHARMACEUTICAL | Immunology | REMICADE®
Sales by segment of business
Sales to customers	$ 1,136	1,379	$ 3,345	4,088
Percent Change (as a percent)	(17.60%)		(18.20%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S.
Sales by segment of business
Sales to customers	$ 749	987	$ 2,324	2,821
Percent Change (as a percent)	(24.10%)		(17.60%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports
Sales by segment of business
Sales to customers	$ 88	100	$ 226	346
Percent Change (as a percent)	(12.00%)		(34.70%)
PHARMACEUTICAL | Immunology | REMICADE® | International
Sales by segment of business
Sales to customers	$ 299	292	$ 795	921
Percent Change (as a percent)	2.50%		(13.70%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®
Sales by segment of business
Sales to customers	$ 586	536	$ 1,673	1,602
Percent Change (as a percent)	9.60%		4.50%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.
Sales by segment of business
Sales to customers	$ 313	281	$ 857	779
Percent Change (as a percent)	11.60%		10.00%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International
Sales by segment of business
Sales to customers	$ 273	255	$ 816	823
Percent Change (as a percent)	7.30%		(0.80%)
PHARMACEUTICAL | Immunology | STELARA®
Sales by segment of business
Sales to customers	$ 1,698	1,310	$ 4,661	3,712
Percent Change (as a percent)	29.60%		25.60%
PHARMACEUTICAL | Immunology | STELARA® | U.S.
Sales by segment of business
Sales to customers	$ 1,212	889	$ 3,152	2,460
Percent Change (as a percent)	36.30%		28.10%
PHARMACEUTICAL | Immunology | STELARA® | International
Sales by segment of business
Sales to customers	$ 487	421	$ 1,509	1,252
Percent Change (as a percent)	15.70%		20.50%
PHARMACEUTICAL | Immunology | TREMFYA®
Sales by segment of business
Sales to customers	$ 290	171	$ 742	369
Percent Change (as a percent)	69.00%
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.
Sales by segment of business
Sales to customers	$ 221	143	$ 565	311
Percent Change (as a percent)	54.30%		81.70%
PHARMACEUTICAL | Immunology | TREMFYA® | International
Sales by segment of business
Sales to customers	$ 69	28	$ 177	58
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 2	2	$ 8	7
Percent Change (as a percent)	(4.40%)		13.70%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 2	2	$ 8	7
Percent Change (as a percent)	(4.40%)		13.70%
PHARMACEUTICAL | Infectious Diseases
Sales by segment of business
Sales to customers	$ 839	823	$ 2,547	2,502
Percent Change (as a percent)	1.90%		1.80%
PHARMACEUTICAL | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 418	345	$ 1,162	1,006
Percent Change (as a percent)	21.20%		15.50%
PHARMACEUTICAL | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 421	478	$ 1,385	1,496
Percent Change (as a percent)	(12.00%)		(7.40%)
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine
Sales by segment of business
Sales to customers	$ 218	202	$ 639	623
Percent Change (as a percent)	7.90%		2.60%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 12	13	$ 36	42
Percent Change (as a percent)	(7.30%)		(14.30%)
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International
Sales by segment of business
Sales to customers	$ 206	189	$ 603	581
Percent Change (as a percent)	9.00%		3.80%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
Sales by segment of business
Sales to customers	$ 508	490	$ 1,566	1,460
Percent Change (as a percent)	3.70%		7.30%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.
Sales by segment of business
Sales to customers	$ 373	297	$ 1,032	847
Percent Change (as a percent)	25.40%		21.80%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International
Sales by segment of business
Sales to customers	$ 135	193	$ 534	613
Percent Change (as a percent)	(29.80%)		(12.80%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES
Sales by segment of business
Sales to customers	$ 113	131	$ 342	419
Percent Change (as a percent)	(13.90%)		(18.60%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.
Sales by segment of business
Sales to customers	$ 33	35	$ 94	117
Percent Change (as a percent)	(4.30%)		(19.60%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International
Sales by segment of business
Sales to customers	$ 80	96	$ 248	302
Percent Change (as a percent)	(17.40%)		(18.20%)
PHARMACEUTICAL | Neuroscience
Sales by segment of business
Sales to customers	$ 1,595	1,490	$ 4,762	4,577
Percent Change (as a percent)	7.10%		4.00%
PHARMACEUTICAL | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 785	651	$ 2,172	1,914
Percent Change (as a percent)	20.70%		13.50%
PHARMACEUTICAL | Neuroscience | International
Sales by segment of business
Sales to customers	$ 810	839	$ 2,590	2,663
Percent Change (as a percent)	(3.50%)		(2.70%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate
Sales by segment of business
Sales to customers	$ 193	157	$ 544	513
Percent Change (as a percent)	23.50%		6.10%
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 84	57	$ 196	191
Percent Change (as a percent)	48.20%		2.90%
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | International
Sales by segment of business
Sales to customers	$ 109	100	$ 348	322
Percent Change (as a percent)	9.40%		8.00%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®
Sales by segment of business
Sales to customers	$ 851	749	$ 2,459	2,165
Percent Change (as a percent)	13.70%		13.60%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.
Sales by segment of business
Sales to customers	$ 554	468	$ 1,543	1,306
Percent Change (as a percent)	18.30%		18.10%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International
Sales by segment of business
Sales to customers	$ 297	281	$ 916	859
Percent Change (as a percent)	5.90%		6.70%
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®
Sales by segment of business
Sales to customers	$ 167	175	$ 528	559
Percent Change (as a percent)	(3.80%)		(5.40%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.
Sales by segment of business
Sales to customers	$ 79	76	$ 237	238
Percent Change (as a percent)	4.90%		(0.50%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International
Sales by segment of business
Sales to customers	$ 89	99	$ 292	321
Percent Change (as a percent)	(10.50%)		(9.10%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 384	409	$ 1,231	1,340
Percent Change (as a percent)	(6.60%)		(8.20%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 68	50	$ 196	179
Percent Change (as a percent)	35.30%		9.70%
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 316	359	$ 1,035	1,161
Percent Change (as a percent)	(12.50%)		(10.90%)
PHARMACEUTICAL | Oncology
Sales by segment of business
Sales to customers	$ 2,761	2,588	$ 7,976	7,355
Percent Change (as a percent)	6.70%		8.40%
PHARMACEUTICAL | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 1,171	1,250	$ 3,146	3,268
Percent Change (as a percent)	(6.30%)		(3.70%)
PHARMACEUTICAL | Oncology | International
Sales by segment of business
Sales to customers	$ 1,590	1,338	$ 4,830	4,087
Percent Change (as a percent)	18.80%		18.20%
PHARMACEUTICAL | Oncology | DARZALEX®
Sales by segment of business
Sales to customers	$ 765	498	$ 2,168	1,441
Percent Change (as a percent)	53.50%		50.40%
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.
Sales by segment of business
Sales to customers	$ 402	318	$ 1,123	880
Percent Change (as a percent)	26.10%		27.60%
PHARMACEUTICAL | Oncology | DARZALEX® | International
Sales by segment of business
Sales to customers	$ 363	180	$ 1,045	561
Percent Change (as a percent)			86.20%
PHARMACEUTICAL | Oncology | IMBRUVICA®
Sales by segment of business
Sales to customers	$ 921	705	$ 2,536	1,912
Percent Change (as a percent)	30.60%		32.60%
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.
Sales by segment of business
Sales to customers	$ 447	334	$ 1,163	811
Percent Change (as a percent)	34.00%		43.50%
PHARMACEUTICAL | Oncology | IMBRUVICA® | International
Sales by segment of business
Sales to customers	$ 475	371	$ 1,373	1,101
Percent Change (as a percent)	27.60%		24.60%
PHARMACEUTICAL | Oncology | VELCADE®
Sales by segment of business
Sales to customers	$ 149	271	$ 636	864
Percent Change (as a percent)	(44.80%)		(26.30%)
PHARMACEUTICAL | Oncology | VELCADE® | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Oncology | VELCADE® | International
Sales by segment of business
Sales to customers	$ 149	271	$ 636	864
Percent Change (as a percent)	(44.80%)		(26.30%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate
Sales by segment of business
Sales to customers	$ 741	958	$ 2,118	2,712
Percent Change (as a percent)	(22.70%)		(21.90%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 233	527	$ 616	1,420
Percent Change (as a percent)	(55.80%)		(56.60%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 508	431	$ 1,502	1,292
Percent Change (as a percent)	17.80%		16.20%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 186	156	$ 519	426
Percent Change (as a percent)	18.80%		21.60%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 91	71	$ 245	157
Percent Change (as a percent)	26.70%		54.70%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 95	85	$ 274	269
Percent Change (as a percent)	12.20%		2.10%
PHARMACEUTICAL | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 654	656	$ 2,000	1,906
Percent Change (as a percent)	(0.30%)		4.90%
PHARMACEUTICAL | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 427	425	$ 1,296	1,215
Percent Change (as a percent)	0.50%		6.60%
PHARMACEUTICAL | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 227	231	$ 704	691
Percent Change (as a percent)	(1.60%)		1.90%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®
Sales by segment of business
Sales to customers	$ 347	310	$ 1,001	892
Percent Change (as a percent)	11.70%		12.20%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.
Sales by segment of business
Sales to customers	$ 206	182	$ 581	511
Percent Change (as a percent)	12.90%		13.70%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International
Sales by segment of business
Sales to customers	$ 140	128	$ 419	381
Percent Change (as a percent)	10.10%		10.20%
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® / bosentan
Sales by segment of business
Sales to customers	$ 65	139	$ 285	422
Percent Change (as a percent)	(52.70%)		(32.40%)
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® / bosentan | U.S.
Sales by segment of business
Sales to customers	$ 19	69	$ 121	208
Percent Change (as a percent)	(72.40%)		(41.80%)
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® / bosentan | International
Sales by segment of business
Sales to customers	$ 46	70	$ 164	214
Percent Change (as a percent)	(32.80%)		(23.30%)
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®
Sales by segment of business
Sales to customers	$ 210	171	$ 611	482
Percent Change (as a percent)	23.40%		26.80%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.
Sales by segment of business
Sales to customers	$ 185	154	$ 536	433
Percent Change (as a percent)	20.20%		23.90%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International
Sales by segment of business
Sales to customers	$ 25	17	$ 75	49
Percent Change (as a percent)	52.10%		52.80%
PHARMACEUTICAL | Pulmonary Hypertension | OTHER
Sales by segment of business
Sales to customers	$ 31	36	$ 103	110
Percent Change (as a percent)	(12.60%)		(6.40%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | U.S.
Sales by segment of business
Sales to customers	$ 17	20	$ 58	63
Percent Change (as a percent)	(10.10%)		(8.90%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | International
Sales by segment of business
Sales to customers	$ 15	16	$ 46	47
Percent Change (as a percent)	(15.40%)		(3.00%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 1,316	1,391	$ 3,936	4,426
Percent Change (as a percent)	(5.40%)		(11.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 955	1,026	$ 2,804	3,230
Percent Change (as a percent)	(6.90%)		(13.20%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 360	365	$ 1,131	1,196
Percent Change (as a percent)	(1.30%)		(5.40%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®
Sales by segment of business
Sales to customers	$ 613	612	$ 1,704	1,869
Percent Change (as a percent)	0.10%		(8.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.
Sales by segment of business
Sales to customers	$ 613	612	$ 1,704	1,869
Percent Change (as a percent)	0.10%		(8.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®
Sales by segment of business
Sales to customers	$ 179	190	$ 558	653
Percent Change (as a percent)	(5.80%)		(14.60%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.
Sales by segment of business
Sales to customers	$ 125	150	$ 411	523
Percent Change (as a percent)	(16.60%)		(21.30%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International
Sales by segment of business
Sales to customers	$ 55	40	$ 147	130
Percent Change (as a percent)	33.90%		12.30%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®
Sales by segment of business
Sales to customers	$ 198	255	$ 607	767
Percent Change (as a percent)	(22.40%)		(20.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.
Sales by segment of business
Sales to customers	$ 126	178	$ 387	523
Percent Change (as a percent)	(29.60%)		(26.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International
Sales by segment of business
Sales to customers	$ 72	77	$ 220	244
Percent Change (as a percent)	(5.70%)		(9.80%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER
Sales by segment of business
Sales to customers	$ 325	334	$ 1,067	1,137
Percent Change (as a percent)	(2.20%)		(6.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | U.S.
Sales by segment of business
Sales to customers	$ 91	86	$ 302	315
Percent Change (as a percent)	8.10%		(3.80%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | International
Sales by segment of business
Sales to customers	$ 234	248	$ 765	822
Percent Change (as a percent)	(5.70%)		(6.90%)
MEDICAL DEVICES
Sales by segment of business
Sales to customers	$ 6,383	6,587	$ 19,331	20,326
Percent Change (as a percent)	(3.10%)		(4.90%)
MEDICAL DEVICES | U.S.
Sales by segment of business
Sales to customers	$ 3,057	3,197	$ 9,249	9,623
Percent Change (as a percent)	(4.40%)		(3.90%)
MEDICAL DEVICES | International
Sales by segment of business
Sales to customers	$ 3,326	3,390	$ 10,082	10,703
Percent Change (as a percent)	(1.90%)		(5.80%)
MEDICAL DEVICES | Diabetes Care
Sales by segment of business
Sales to customers	$ 0	315	$ 0	1,009
MEDICAL DEVICES | Diabetes Care | U.S.
Sales by segment of business
Sales to customers	0	125	0	371
MEDICAL DEVICES | Diabetes Care | International
Sales by segment of business
Sales to customers	0	190	0	638
MEDICAL DEVICES | Interventional Solutions
Sales by segment of business
Sales to customers	$ 741	653	$ 2,223	1,960
Percent Change (as a percent)	13.40%		13.40%
MEDICAL DEVICES | Interventional Solutions | U.S.
Sales by segment of business
Sales to customers	$ 357	320	$ 1,066	947
Percent Change (as a percent)	11.50%		12.60%
MEDICAL DEVICES | Interventional Solutions | International
Sales by segment of business
Sales to customers	$ 382	333	$ 1,156	1,013
Percent Change (as a percent)	15.30%		14.20%
MEDICAL DEVICES | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,138	2,111	$ 6,566	6,623
Percent Change (as a percent)	1.20%		(0.90%)
MEDICAL DEVICES | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,301	1,284	$ 3,950	3,923
Percent Change (as a percent)	1.20%		0.70%
MEDICAL DEVICES | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 837	827	$ 2,616	2,700
Percent Change (as a percent)	1.20%		(3.10%)
MEDICAL DEVICES | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 336	330	$ 1,061	1,053
Percent Change (as a percent)	1.70%		0.70%
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 204	201	$ 633	621
Percent Change (as a percent)	1.10%		1.80%
MEDICAL DEVICES | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 133	129	$ 428	432
Percent Change (as a percent)	2.70%		(0.80%)
MEDICAL DEVICES | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 344	341	$ 1,085	1,110
Percent Change (as a percent)	1.20%		(2.20%)
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 209	215	$ 650	672
Percent Change (as a percent)	(2.70%)		(3.30%)
MEDICAL DEVICES | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 136	126	$ 435	438
Percent Change (as a percent)	7.90%		(0.60%)
MEDICAL DEVICES | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 677	654	$ 2,034	2,025
Percent Change (as a percent)	3.50%		0.40%
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 415	395	$ 1,239	1,196
Percent Change (as a percent)	5.10%		3.60%
MEDICAL DEVICES | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 262	259	$ 795	829
Percent Change (as a percent)	1.00%		(4.10%)
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER
Sales by segment of business
Sales to customers	$ 778	786	$ 2,384	2,435
Percent Change (as a percent)	(0.90%)		(2.10%)
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 472	473	$ 1,427	1,434
Percent Change (as a percent)	(0.20%)		(0.50%)
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | International
Sales by segment of business
Sales to customers	$ 306	313	$ 957	1,001
Percent Change (as a percent)	(2.00%)		(4.40%)
MEDICAL DEVICES | Surgery
Sales by segment of business
Sales to customers	$ 2,311	2,376	$ 7,059	7,314
Percent Change (as a percent)	(2.70%)		(3.50%)
MEDICAL DEVICES | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 940	1,016	$ 2,867	3,031
Percent Change (as a percent)	(7.40%)		(5.40%)
MEDICAL DEVICES | Surgery | International
Sales by segment of business
Sales to customers	$ 1,371	1,360	$ 4,192	4,283
Percent Change (as a percent)	0.80%		(2.10%)
MEDICAL DEVICES | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 1,010	976	$ 3,019	2,947
Percent Change (as a percent)	3.60%		2.40%
MEDICAL DEVICES | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 409	421	$ 1,209	1,216
Percent Change (as a percent)	(2.80%)		(0.60%)
MEDICAL DEVICES | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 602	555	$ 1,811	1,731
Percent Change (as a percent)	8.30%		4.60%
MEDICAL DEVICES | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,101	1,080	$ 3,309	3,376
Percent Change (as a percent)	1.90%		(2.00%)
MEDICAL DEVICES | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 443	423	$ 1,311	1,282
Percent Change (as a percent)	4.70%		2.30%
MEDICAL DEVICES | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 659	657	$ 1,998	2,094
Percent Change (as a percent)	0.20%		(4.60%)
MEDICAL DEVICES | Surgery | SPECIALTY
Sales by segment of business
Sales to customers	$ 200	320	$ 731	991
Percent Change (as a percent)	(37.40%)		(26.20%)
MEDICAL DEVICES | Surgery | SPECIALTY | U.S.
Sales by segment of business
Sales to customers	$ 88	172	$ 347	533
Percent Change (as a percent)	(48.00%)		(34.90%)
MEDICAL DEVICES | Surgery | SPECIALTY | International
Sales by segment of business
Sales to customers	$ 110	148	$ 383	458
Percent Change (as a percent)	(25.00%)		(16.20%)
MEDICAL DEVICES | Vision
Sales by segment of business
Sales to customers	$ 1,193	1,132	$ 3,483	3,420
Percent Change (as a percent)	5.40%		1.80%
MEDICAL DEVICES | Vision | U.S.
Sales by segment of business
Sales to customers	$ 459	452	$ 1,366	1,351
Percent Change (as a percent)	1.40%		1.10%
MEDICAL DEVICES | Vision | International
Sales by segment of business
Sales to customers	$ 734	680	$ 2,117	2,069
Percent Change (as a percent)	8.00%		2.30%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 893	835	$ 2,559	2,486
Percent Change (as a percent)	7.00%		2.90%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 339	319	$ 993	948
Percent Change (as a percent)	6.20%		4.70%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 555	516	$ 1,566	1,538
Percent Change (as a percent)	7.40%		1.80%
MEDICAL DEVICES | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 299	297	$ 923	934
Percent Change (as a percent)	0.90%		(1.10%)
MEDICAL DEVICES | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 120	133	$ 373	403
Percent Change (as a percent)	(10.00%)		(7.40%)
MEDICAL DEVICES | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 180	$ 164	$ 551	$ 531
Percent Change (as a percent)	9.90%		3.70%